Search results
Alzheimer's drug that can slow disease gets backing from FDA advisers
KABC 7 Los Angeles· 21 minutes agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia ...
Eli Lilly's Alzheimer's drug gets backing from FDA advisers
Morningstar· 15 hours agoEli Lilly & Co.'s experimental Alzheimer's drug donanemab on Monday moved a step closer to U.S. regulatory approval as it won support from an independent panel of advisers to the Food and Drug ...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
Hawaii News Now· 15 hours agoA closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia ...
Dow Jones Futures Fall; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
Investor's Business Daily· 23 hours agoBut there are potentially serious side effects. Eli Lilly stock has boomed over the past year...
Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers
Fortune· 2 hours agoFood and Drug Administration advisers voted unanimously that the drug’s ability to slow the disease outweighs its risks, including side effects like brain swelling and bleeding that will have ...
Alzheimer’s drug that can slow disease gets backing from FDA advisers
WYMT Eastern Kentucky· 15 hours agoA closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia ...
Alzheimer's drug that can slow disease gets backing from FDA advisers
Minneapolis-St. Paul Star Tribune· 15 hours agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia ...
FDA panel approves Alzheimer's drug that can slow disease
First Coast News· 15 hours agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...
Unanimous FDA panel backs Lilly Alzheimer's drug
Axios· 12 hours agoA unanimous panel of federal drug advisers on Monday concluded that Eli Lilly's experimental Alzheimer's drug donanemab benefits patients with early...
Alzheimer's drug that can slow disease gets backing from FDA advisers
San Francisco Chronicle· 14 hours agoA closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on...